-
EP1312377
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1312377
| EP1312377 - Combined meningitis vaccine [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.05.2011 Database last updated on 11.04.2026 | Most recent event Tooltip | 20.05.2011 | Application deemed to be withdrawn | published on 22.06.2011 [2011/25] | Applicant(s) | For all designated states Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina 1 53100 Siena (SI) / IT | [N/P] |
| Former [2007/04] | For all designated states Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina 1 53100 Siena SI / IT | ||
| Former [2004/02] | For all designated states Chiron S.r.l. Via Fiorentina, 1 53100 Siena / IT | ||
| Former [2003/21] | For all designated states Chiron S.p.A. Via Fiorentina, 1 53100 Siena / IT | Inventor(s) | 01 /
Ceccarini, Costante Chrion SpA, Via Fiorentina 1 53100 Siena / IT | 02 /
d'Ascenzi, Sandro Chrion SpA, Via Fiorentina 1 53100 Siena / IT | 03 /
Costantino, Paolo Chrion SpA, Via Fiorentina 1 53100 Siena / IT | 04 /
Norelli, Francesco Chrion SpA, Via Fiorentina 1 53100 Siena / IT | 05 /
Giannozzi, Aldo Chrion SpA, Via Fiorentina 1 53100 Siena / IT | [2003/21] | Representative(s) | Marshall, Cameron John, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2009/51] | Marshall, Cameron John, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB | ||
| Former [2003/21] | Marshall, Cameron John, et al Carpmaels & Ransford 43 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 03075069.9 | 02.11.1995 | [2003/21] | Priority number, date | GB19940022096 | 02.11.1994 Original published format: GB 9422096 | [2003/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1312377 | Date: | 21.05.2003 | Language: | EN | [2003/21] | Type: | A3 Search report | No.: | EP1312377 | Date: | 04.02.2004 | [2004/06] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 12.12.2003 | Classification | IPC: | A61K39/02, A61K39/095, A61K39/102 | [2003/21] | CPC: |
A61K39/102 (EP,US);
A61K39/095 (EP,US);
A61P31/04 (EP);
A61P37/04 (EP);
A61K2039/6037 (EP,US);
A61K2039/70 (EP,US);
Y10S424/831 (EP,US)
(-)
| C-Set: |
A61K39/102, A61K2300/00 (US,EP);
A61K39/102, A61K39/095 (EP,US) | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2003/21] | Title | German: | Kombiniertes Meningitis Vakzin | [2003/21] | English: | Combined meningitis vaccine | [2003/21] | French: | Vaccin polyvalent anti-meningite | [2003/21] | Examination procedure | 12.07.2004 | Examination requested [2004/37] | 07.08.2007 | Despatch of a communication from the examining division (Time limit: M04) | 13.12.2007 | Reply to a communication from the examining division | 28.03.2008 | Despatch of a communication from the examining division (Time limit: M04) | 07.08.2008 | Reply to a communication from the examining division | 24.06.2009 | Despatch of a communication from the examining division (Time limit: M06) | 04.01.2010 | Reply to a communication from the examining division | 16.07.2010 | Observations by third parties | 20.08.2010 | Despatch of a communication from the examining division (Time limit: M04) | 31.12.2010 | Application deemed to be withdrawn, date of legal effect [2011/25] | 03.02.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/25] | Parent application(s) Tooltip | EP95935550.4 / EP0789587 | Divisional application(s) | EP10075114.8 / EP2204185 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19950935550) is 04.05.2001 | Fees paid | Renewal fee | 10.01.2003 | Renewal fee patent year 03 | 10.01.2003 | Renewal fee patent year 04 | 10.01.2003 | Renewal fee patent year 05 | 10.01.2003 | Renewal fee patent year 06 | 10.01.2003 | Renewal fee patent year 07 | 10.01.2003 | Renewal fee patent year 08 | 08.03.2004 | Renewal fee patent year 09 | 22.11.2004 | Renewal fee patent year 10 | 07.11.2005 | Renewal fee patent year 11 | 06.11.2006 | Renewal fee patent year 12 | 15.11.2007 | Renewal fee patent year 13 | 31.03.2008 | Renewal fee patent year 14 | 12.11.2009 | Renewal fee patent year 15 | Penalty fee | Additional fee for renewal fee | 30.11.2003 | 09 M06 Fee paid on 08.03.2004 | 30.11.2010 | 16 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] SIBER G R ET AL: "Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease.", ANNALS OF INTERNAL MEDICINE. UNITED STATES APR 1986, vol. 104, no. 4, April 1986 (1986-04-01), pages 467 - 475, XP009017166, ISSN: 0003-4819 [X] 1,2,12-14,16 * abstract * * page 469; table 2 * * page 473, column 1, paragraph 3 - column 2, paragraph 1 * * page 474, column 2, paragraph 2 * | [X] AMBROSINO D M ET AL: "Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.", THE JOURNAL OF CLINICAL INVESTIGATION. UNITED STATES JUN 1985, vol. 75, no. 6, June 1985 (1985-06-01), pages 1935 - 1942, XP009017168, ISSN: 0021-9738 [X] 1,2,12-14,16 * abstract * * page 1935, column 2, paragraph 4 - page 1936, column 1, paragraph 1 * DOI: http://dx.doi.org/10.1172/JCI111909 | [Y] WATEMBERG N ET AL: "SAFETY AND IMMUNOGENICITY OF HAEMOPHILUS TYPE B-TETANUS PROTEIN CONJUGATE VACCINE, MIXED IN THE SAME SYRINGE WITH DIPHTHERIA-TETANUS-PERTUSSIS VACCINE IN YOUNG INFANTS", PEDIATR INFECT DISEASE JOURNAL, BALTIMORE, MD, US, vol. 10, no. 10, 1991, pages 758 - 763, XP000847642 [Y] 1,2,6-14,16-18 * abstract * * page 758, column 2, paragraph 5 - page 759, column 1, paragraph 2 * | [Y] GURIN N: "[Control of Haemophilus influenzae infections]", SANTE (MONTROUGE, FRANCE) FRANCE 1994 MAY-JUN, vol. 4, no. 3, May 1994 (1994-05-01), pages 227 - 230, XP009017167, ISSN: 1157-5999 [Y] 1,2,6-14,16-18 * page 228, column 1, paragraph 10 - column 3, paragraph 1; table 1 * * page 229, column 2, paragraph 5 * * page 230, column 1, paragraph 3 - column 2, paragraph 1 * | [Y] HRONOWSKI L ET AL: "Structure activity studies on Neisseria meningitidis group C polysaccharide-protein conjugate vaccines: The effect of O-acetylation on the nature of the antibody response.", ABSTRACTS OF THE GENERAL MEETING OF THE AMERICAN SOCIETY FOR, vol. 93, 1993, 93rd General Meeting of the American Society for Microbiology;Atlanta, Georgia, USA; May 16-20, 1993, 1993, pages 155, XP009017164, ISSN: 1060-2011 [Y] 1,2,6-14,16-18 * abstract * | [Y] AMBROSINO D M ET AL: "Response to Haemophilus influenzae type B conjugate vaccine in children undergoing splenectomy", JOURNAL OF PEDIATRIC SURGERY 1992 UNITED STATES, vol. 27, no. 8, 1992, pages 1045 - 1048, XP009017160, ISSN: 0022-3468 [Y] 1,2,6-14,16-18 * abstract * * page 1046, column 2, paragraphs 2,3 * * page 1047, column 2, paragraph 2 * |